|
Market Closed -
Hong Kong S.E.
06:08:09 17/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 25.94 HKD | +2.37% |
|
-3.35% | -25.72% |
| 27/08 | CanSino Biologics Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 26/08 | CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines | MT |
| Market Cap | 10.5B 12.28B 1.56B 1.36B 1.28B 1.16B 2.18B 150B 2.19B 15.3B 5.91B 76.15B 5.88B 5.75B 243B | P/E 2026 * |
49.7x | P/E 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 10.52B 12.3B 1.57B 1.36B 1.28B 1.17B 2.19B 150B 2.2B 15.34B 5.93B 76.32B 5.89B 5.76B 243B | EV / Sales 2026 * |
7.3x | EV / Sales 2027 * | 6.02x |
| Free-Float |
39.3% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 6185 | Delayed | |
OTC Markets
| CASBF | Delayed | |
Tradegate
| CJH | Real-time | |
Börse Stuttgart
| CJH | Delayed | |
Deutsche Boerse AG
| CJH | Delayed | |
Boerse Muenchen
| CJH | Real-time |
| 1 day | +2.37% | ||
| 1 week | -3.35% | ||
| Current month | -12.07% | ||
| 1 month | +3.59% | ||
| 3 months | +16.01% | ||
| 6 months | -23.71% | ||
| Current year | -25.72% |
| 1 week | 25.08 | 27.36 | |
| 1 month | 23.16 | 40 | |
| Current year | 19.22 | 41.64 | |
| 1 year | 19.22 | 54.65 | |
| 3 years | 14.8 | 56.55 | |
| 5 years | 14.8 | 289.4 | |
| 10 years | 14.8 | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dong Xu Qiu
PRN | Corporate Officer/Principal | 66 | 21/02/2024 |
Hui Hua Mao
PRN | Corporate Officer/Principal | 64 | 13/01/2009 |
Tao Zhu
CTO | Chief Tech/Sci/R&D Officer | 53 | 13/01/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Yu
CHM | Chairman | 62 | 13/01/2009 |
Zhong Qi Shao
BRD | Director/Board Member | 63 | 28/05/2021 |
Shou Bai Chao
BRD | Director/Board Member | 63 | 22/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/8/25 | Sell | Director | 4,600 | 0.0069% | ||
| 26/9/24 | Other | Chief Executive Officer | 20,000 | 0.0151% | ||
| 9/9/24 | Other | Founder | 30,000 | 0.0226% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.37% | -3.35% | -51.24% | +4.60% | 1.53B | ||
| +0.39% | -4.09% | +34.70% | -5.93% | 77.35B | ||
| +1.81% | +4.76% | -11.69% | -33.17% | 59.58B | ||
| +4.45% | +7.38% | +486.23% | +27.08% | 58.14B | ||
| -0.21% | -2.96% | -11.54% | +25.36% | 47.62B | ||
| +0.63% | +2.83% | +2.17% | +150.18% | 45.34B | ||
| +0.77% | +2.51% | +50.34% | -15.22% | 31.92B | ||
| +1.25% | -1.00% | +48.69% | +99.44% | 25.29B | ||
| +2.18% | +1.91% | -0.36% | +141.28% | 20.88B | ||
| +1.23% | +1.19% | +61.93% | +101.45% | 15.64B | ||
| Average | +1.40% | -1.02% | +60.92% | +49.51% | 38.33B | |
| Weighted average by Cap. | +1.28% | +0.38% | +87.47% | +35.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.44B 1.68B 215M 186M 176M 160M 299M 20.6B 301M 2.1B 811M 10.45B 807M 789M 33.3B | 1.81B 2.12B 270M 234M 221M 201M 377M 25.92B 379M 2.64B 1.02B 13.15B 1.01B 992M 41.9B |
| Net income | 107M 125M 15.95M 13.82M 13.07M 11.86M 22.23M 1.53B 22.36M 156M 60.27M 776M 59.92M 58.59M 2.47B | 322M 377M 48.04M 41.63M 39.35M 35.72M 66.95M 4.61B 67.35M 470M 182M 2.34B 180M 176M 7.45B |
| Net Debt | 24.02M 28.09M 3.58M 3.1M 2.93M 2.66M 4.99M 344M 5.02M 35.02M 13.53M 174M 13.45M 13.15M 555M | 415M 485M 61.89M 53.63M 50.69M 46.02M 86.25M 5.94B 86.76M 605M 234M 3.01B 232M 227M 9.6B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/09/26 | HKD 25.94 | +2.37% | 4,452,600 |
| 16/09/26 | HKD 25.34 | -0.94% | 2,290,600 |
| 15/09/26 | HKD 25.58 | -3.33% | 2,413,391 |
| 14/09/26 | HKD 26.46 | +2.56% | 4,553,200 |
| 11/09/26 | HKD 25.80 | -3.87% | 3,273,454 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6185 Stock
Select your edition
All financial news and data tailored to specific country editions


















